Arthritis

  1. Home
  2. Health
  3. Arthritis
photo of Carol & Richard Eustice

Arthritis Blog

By Carol & Richard Eustice, About.com Guides to Arthritis since 1997

Prescription Drug Prices Rising Faster Than Inflation

Monday July 3, 2006
Prescription drug prices are rising faster than the rate of inflation according to several reports. Seniors and disabled persons who signed up for the Medicare Part D prescription drug plan are noticing that prices have continued to soar. The wholesale cost of brand-name prescription drugs has gone up nearly 4 percent since January. AARP reports that manufacturer prices went up 3.9 percent from January-March 2006 for nearly 200 of the most commonly used brand name medications, triple the rate of inflation.

ABCNEWS.com reports some drug prices are up even more:

  • Celebrex (arthritis medication) - up 6.5 percent
  • Ambien (sleep medication) - up 13.3 percent

Why are prices soaring for Medicare D beneficiaries? Medicare Part D gives the power of negotiating lower drug prices to individual plans rather than giving the power to the government (i.e. Medicare). In defense, the Centers for Medicare & Medicaid Services has released a study showing that private drug plans are negotiating large discounts for Medicare beneficiaries. While seniors and people who need prescription drugs to treat chronic illnesses are caught in the crosshairs of the political debate, it is clear drug prices have been going up significantly.

Photo by Stefan Klein (iStockphoto)

Comments

No comments yet. Leave a Comment

Leave a Comment

Line and paragraph breaks are automatic. Some HTML allowed: <a href="" title="">, <b>, <i>, <strike>

Discuss

Community Forum

Explore Arthritis

About.com Special Features

Do I Have Allergies?

Are your symptoms merely irritating, or could they be a sign of allergies? More >

Preventing Headaches

The best way to treat a headache is to prevent it. Learn how. More >

Arthritis

  1. Home
  2. Health
  3. Arthritis

©2009 About.com, a part of The New York Times Company.

All rights reserved.